Addressing Detection and Prevention Gaps to Reduce First-Time Heart Attack Risks

New research highlights critical gaps in detecting and preventing first-time heart attacks, emphasizing the need for advanced diagnostic tools and proactive care strategies to save lives.
Despite widespread use of traditional risk assessment tools for atherosclerotic cardiovascular disease, the global incidence of heart attacks continues to climb. Recent research, led by Nick Nurmohamed in collaboration with Mount Sinai and published in the European Heart Journal, highlights significant gaps in detecting at-risk individuals before their initial myocardial infarction (MI).
Analyzing data from nearly 5 million Americans, the study reveals deficiencies in identifying early symptoms and implementing preventive therapies. Notably, younger patients aged 60 or below, especially men, often exhibit fewer documented risk factors or symptoms and are less likely to consult primary care providers. This subgroup is also more prone to experiencing severe ST-elevation MIs.
Conversely, older adults and women tend to have more recorded risk factors and symptoms but still encounter inadequate preventive measures. These disparities emphasize the urgent need for more effective diagnostic tools and proactive management strategies.
Nurmohamed emphasizes the importance of developing advanced blood tests and imaging techniques to identify high-risk individuals earlier, even in the absence of symptoms. The prototype approaches currently under investigation aim to enhance early detection, potentially saving lives and reducing healthcare costs.
This research underscores a critical gap in cardiovascular prevention efforts and advocates for innovative solutions to better predict and prevent the first occurrence of heart attacks. Early intervention and improved risk stratification could significantly decrease the burden of this leading cause of death worldwide.
Source: https://medicalxpress.com/news/2025-07-gaps-vulnerable-heart.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Approach to Developing a Universal Antiviral Therapy
A groundbreaking mRNA-based therapy aims to mimic a rare immune deficiency, providing broad protection against multiple viruses and paving the way for a universal antiviral treatment.
US Pediatricians Recommend Diverging COVID-19 Vaccination Guidelines from CDC
The American Academy of Pediatrics has issued new COVID-19 vaccination recommendations for children, diverging from CDC guidance for the first time in 30 years, emphasizing vaccination for ages 6 months to 2 years and high-risk groups.
Microbiota's Future Role in Diagnostics and Therapy: Insights from Experts
Experts predict that microbiota-based diagnostics and therapies will become a cornerstone of personalized medicine within the next decade, transforming clinical practice through biomarker development and innovative treatments.



